Search Results

35 results

  1. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 29

    Thermochemical and thermophysical mapping of burning superslim and kingsize cigarettes

    EHLERT S.(1,3); CUI H.(2); HEIDE J.(3); XIE F.(2); DENG N.(2); LIU C.(4); McADAM K.(4); WALTE A.(1); ZIMMERMANN R.(3)
    (1) Photonion GmbH, Schwerin, Germany; (2) Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, P.R. China; (3) University of Rostock, Dept. of Analytical Chemistry, Rostock, Germany; (4) British American Tobacco, R&D Centre, Southampton, U.K.
    After presenting and publishing the proof of principle of the in-situ thermochemical and thermophysical mapping inside a burning Super Slim (SS) cigarette, we now extended the study scope to other cigarette formats and smoking regimes[1]. A...
  2. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 33 (also presented at TSRC 2018)

    Comparison of potential health risks of combustible, heat-not-burn, and electronic cigarettes

    LIU C.; MARANO K.
    RAI Services Company, Winston-Salem, NC, U.S.A.
    Given U.S. Food and Drug Administration (FDA) regulation of tobacco products via the Family Smoking Prevention and Tobacco Control Act, there is a growing recognition of the need for evidence to assist both applicants and the FDA in making...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 40

    FDA’s proposed NNN product standard: review of the scientific evidence

    MARANO K.M.(1); BACHAND A.(2); LIU C.(1); SULSKY S.(2); MARIANO G.(2); CURTIN G.M.(1); PARMS T.(1); GREEN T.(3); GENTRY P.R.(3)
    (1) RAI Services Co., Winston-Salem, NC, U.S.A.; (2) Ramboll Environ US Corp., Amherst, MA, U.S.A.; (3) Ramboll Environ, Monroe, LA, U.S.A.
    The U.S. Food and Drug Administration (FDA) has published a proposed standard of 1 µg/g (dry weight) N-nitrosonornicotine (NNN) in finished smokeless tobacco products. FDA’s rationale for the standard is that NNN is a potent carcinogen, NNN is a...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, STPOST 37

    FDA’s proposed NNN product standard: quantitative risk assessment

    MARANO K.M.(1); GENTRY P.R.(2); LIU C.(1)
    (1) RAI Services Co., Winston-Salem, NC, U.S.A.; (2) Ramboll Environ, Monroe, LA, U.S.A.
    The U.S. Food and Drug Administration (FDA) has published a proposed standard for N-nitrosonornicotine (NNN) content in finished smokeless tobacco products. The proposed NNN limit of 1 part per million (ppm) dry weight was derived based on a target...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, STPOST 48

    The in vitro biological assessment of a novel hybrid tobacco product and comparison with a cigarette smoke

    BREHENY D.; ADAMSON J.; AZZOPARDI D.; BAXTER A.; BISHOP E.; CARR T.; CROOKS I.; HEWITT K.; JAUNKY T.; LARARD S.; LOWE F.; OKE O.; TAYLOR M.; SANTOPIETRO S.; THORNE D.; ZAINUDDIN B.; GAҪA M.; LIU C.; MURPHY J.; PROCTOR C.
    British American Tobacco (Investments) Limited, R&D, Southampton, U.K.
    Cigarette smoking is a risk factor for many diseases including cardiovascular disease, lung disease, and cancer. Recently there has been an increase in the development and consumer acceptance of novel nicotine and tobacco products including...